Literature DB >> 22124735

Role of the ubiquitin ligase Fbw7 in cancer progression.

Yabin Cheng1, Gang Li.   

Abstract

Fbw7 is a member of F-box family proteins, which constitute one subunit of Skp1, Cul1, and F-box protein (SCF) ubiquitin ligase complex. SCF(Fbw7) targets a set of well-known oncoproteins, including c-Myc, cyclin E, Notch, c-Jun, and Mcl-1, for ubiquitylation and degradation. Fbw7 provides specificity of the ubiquitylation of these substrate proteins via recognition of a consensus phosphorylated degron. Through regulation of several important proteins, Fbw7 controls diverse cellular processes, including cell-cycle progression, cell proliferation, differentiation, DNA damage response, maintenance of genomic stability, and neural cell stemness. As reduced Fbw7 expression level and loss-of-function mutations are found in a wide range of human cancers, Fbw7 is generally considered as a tumor suppressor. However, the exact mechanisms underlying Fbw7-induced tumor suppression is unclear. This review focuses on regulation network, biological functions, and genetic alteration of Fbw7 in connection with its role in cancer development.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22124735     DOI: 10.1007/s10555-011-9330-z

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  54 in total

Review 1.  New insights to the ubiquitin-proteasome pathway (UPP) mechanism during spermatogenesis.

Authors:  Cong-Cong Hou; Wan-Xi Yang
Journal:  Mol Biol Rep       Date:  2012-12-26       Impact factor: 2.316

Review 2.  Role of ubiquitin ligases and the proteasome in oncogenesis: novel targets for anticancer therapies.

Authors:  Lindsey N Micel; John J Tentler; Peter G Smith; Gail S Eckhardt
Journal:  J Clin Oncol       Date:  2013-01-28       Impact factor: 44.544

3.  FBW7 increases drug sensitivity to cisplatin in human nasopharyngeal carcinoma by downregulating the expression of multidrug resistance-associated protein.

Authors:  Yan Song; Xinjia Zhou; Weiliang Bai; Xiulan Ma
Journal:  Tumour Biol       Date:  2015-01-14

Review 4.  Ubiquitylation at the crossroads of development and disease.

Authors:  Michael Rape
Journal:  Nat Rev Mol Cell Biol       Date:  2017-09-20       Impact factor: 94.444

5.  MicroRNA-25 promotes gastric cancer proliferation, invasion, and migration by directly targeting F-box and WD-40 Domain Protein 7, FBXW7.

Authors:  Junhua Gong; Zheng Cui; Li Li; Qiang Ma; Qiufang Wang; Yinhe Gao; Hao Sun
Journal:  Tumour Biol       Date:  2015-05-06

Review 6.  Recent advances in SCF ubiquitin ligase complex: Clinical implications.

Authors:  Nana Zheng; Quansheng Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2016-05-05

7.  Exome Sequencing Identifies Potentially Druggable Mutations in Nasopharyngeal Carcinoma.

Authors:  Yock Ping Chow; Lu Ping Tan; San Jiun Chai; Norazlin Abdul Aziz; Siew Woh Choo; Paul Vey Hong Lim; Rajadurai Pathmanathan; Noor Kaslina Mohd Kornain; Chee Lun Lum; Kin Choo Pua; Yoke Yeow Yap; Tee Yong Tan; Soo Hwang Teo; Alan Soo-Beng Khoo; Vyomesh Patel
Journal:  Sci Rep       Date:  2017-03-03       Impact factor: 4.379

8.  Identification of aberrantly expressed F-box proteins in squamous-cell lung carcinoma.

Authors:  Kai Wang; Xiao Qu; Shaorui Liu; Xudong Yang; Fenglong Bie; Yu Wang; Cuicui Huang; Jiajun Du
Journal:  J Cancer Res Clin Oncol       Date:  2018-05-04       Impact factor: 4.553

9.  Evaluating the prognostic significance of FBXW7 expression level in human breast cancer by a meta-analysis of transcriptional profiles.

Authors:  Guangwei Wei; Yunshan Wang; Pengju Zhang; Jing Lu; Jian-Hua Mao
Journal:  J Cancer Sci Ther       Date:  2012-08-31

10.  Rapamycin inhibits FBXW7 loss-induced epithelial-mesenchymal transition and cancer stem cell-like characteristics in colorectal cancer cells.

Authors:  Yuli Wang; Yueyong Liu; Jing Lu; Pengju Zhang; Yunshan Wang; Yangyang Xu; Zeran Wang; Jian-Hua Mao; Guangwei Wei
Journal:  Biochem Biophys Res Commun       Date:  2013-04-02       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.